Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 3,000 shares at $411.62 ($1.2M) on 2026-10-01, disclosed to the SEC on 2026-10-02.
Scheduled sale ($1.2M) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $411.62 | 200 | $82K | 6.6% |
| 2 | $413.11 | 954 | $394K | 31.7% |
| 3 | $415.07 | 1,846 | $766K | 61.7% |
| Total | $414.22 avg | 3,000 | $1.2M | 100% |
| Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |
| NTRA | SELL | 2026-06-03 | $655K | — | Filing → |